BSE filing, NSE: CTE. Summary written from the filing by ALFA Finder's alert engine.
Cambridge Technology Enterprises Ltd: key numbers
- Share price
- ₹37.20
- Market cap
- ₹73.03 Cr
- Revenue (annual)
- ₹181.0 Cr
- Net profit (annual)
- ₹0.48 Cr
- P/E (TTM)
- 10.5×Sector 22.9×
- Promoter holding
- 57.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cambridge Technology Enterprises Ltd
All →Cambridge Technology Enterprises Other Announcement
The company submitted its quarterly certificate for the period ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Cambridge Technology Enterprises Management Change
Cambridge Technology Enterprises Limited appointed M/s. S B C & Co. as Statutory Auditors for five years. They replace M/s. B R A N D LLP & Co.
- Execution
- 5 consecutive years
Cambridge Technology Enterprises Annual General Meeting
Shareholders at Cambridge Technology Enterprises' AGM approved the assignment of a Rs. 15.22 crore loan for Rs. 0.40 crore consideration, alongside other routine annual agenda items.
- Value
- ₹0.40 Cr
Cambridge Technology Enterprises Annual General Meeting
Cambridge Technology Enterprises Limited held its 27th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of financial statements and the transfer of a loan receivable.
Cambridge Technology Enterprises Other Announcement
Cambridge Technology Enterprises notified exchanges regarding the dispatch of annual report links to shareholders. It also included instructions for physical shareholders to update KYC details.
Cambridge Technology Enterprises Annual General Meeting
Cambridge Technology Enterprises Limited will hold its 27th Annual General Meeting on September 29, 2026. The share transfer books will close from September 23, 2026.
Other management change announcements
All →Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Mobavenue AI Tech Management Change
Mobavenue AI Tech appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. He will lead fundraising, acquisitions and investor relations.
Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.